SCHEMBL9944838

SCHEMBL9944838

CCNC(=O)c1cc([N+](=O)[O-])c(NC)cc1N(C)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HCAR3 P49019 3/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 4/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CDC25B P30305 1/20 0.34
CA2 P00918 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GALR2 O43603 1/20 0.33
MITF O75030 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HPGD P15428 1/20 0.33
XBP1 P17861 1/20 0.33
CCR6 P51684 1/20 0.33
JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944844 0.96 ALDH1A1 (0.45) ALDH1A1MAPTNPSR1HCAR3HTT
SCHEMBL9944994 0.88 ALDH1A1 (0.42) ALDH1A1MAPTNPSR1HCAR3HTT
SCHEMBL9944852 0.82 HCAR3 (0.46) ALDH1A1MAPTNPSR1HCAR3HTT
SCHEMBL9944839 0.81 ALOX15 (0.40) ALDH1A1MAPTNPSR1CA2
SCHEMBL9944903 0.79 ALDH1A1 (0.42) ALDH1A1MAPTNPSR1HCAR3HTT
SCHEMBL9944845 0.77 ALOX15 (0.44) ALDH1A1MAPTNPSR1CA2
SCHEMBL9944752 0.76 HCAR3 (0.43) ALDH1A1MAPTNPSR1HCAR3HTT
SCHEMBL9944820 0.74 ALDH1A1 (0.39) ALDH1A1MAPTPOLBHPGD
SCHEMBL9944846 0.74 KMT2A (0.47) ALDH1A1MAPTHTTLMNASMN1; SMN2
SCHEMBL9944856 0.74 PTGES (0.39) ALDH1A1MAPTNPSR1HCAR3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885MAPT 4336/4885NPSR1 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.